[1]
|
“Cancer/Anticancer Peptides Section, Part VII,” In: A. J. Kasten, Ed., Handbook of Biologically Active Peptides, Academic Press, Waltham, 2006.
http://www.sciencedirect.com/science/book/9780123694423#ancSE7.
|
[2]
|
R. M. Freidenger, “Design and Synthesis of Novel Bioactive Peptides and Peptidomimetics,” Journal of Medicinal Chemistry, Vol. 46, No. 26, 2003, pp. 5553-5566.
doi:10.1021/jm030484k
|
[3]
|
P. B. McKay, M. B. Peters, G. Carta, C. T. Flood, E. Dempsey, A. Bell, C. Berry, D. G. Lloyd and D. Fayne, “Identification of Plasmepsin Inhibitors as Selective Antimalarial Agents Using Ligand Based Drug Design,” Bioorganic & Medicinal Chemistry Letters, Vol. 21, No. 11, 2011, pp. 3335-3341. doi:10.1016/j.bmcl.2011.04.015
|
[4]
|
T. T. H. Nguyen, H. Ryu, S. Lee, S. Hwang, V. Breton, J. H. Rhee and D. Kim, “Virtual Screening Identification of Novel Severe Acute Respiratory Syndrome 3C-Like Protease Inhibitors and in Vitro Confirmation,” Bioorganic & Medicinal Chemistry Letters, Vol. 21, No. 10, 2011, pp. 3088-3091. doi:10.1016/j.bmcl.2011.03.034
|
[5]
|
Y. K. Peterson, X. S. Wang, P. J. Casey and A. Tropsha, “Discovery of Geranylgeranyltransferase-I Inhibitors with Novel Scaffolds by the Means of Quantitative Structur-Activity Relationship Modeling, Virtual Screening, and Experimental Validation,” Journal of Medicinal Chemistry, Vol. 52, No. 14, 2009, pp. 4210-4220.
doi:10.1021/jm8013772
|
[6]
|
R. B. Perni, S. C. Conway, S. K. Ladner, K. Zaifert, M. J. Otto and R. W. King, “Phenylpropenamide Derivatives as Inhibitors of Hepatitis B Virus Replication,” Bioorganic & Medicinal Chemistry Letters, Vol. 10, No. 23, 2000, pp. 2687-2690. doi:10.1016/S0960-894X(00)00544-8
|
[7]
|
E. M. Al-Arab, B. Ezz, M. Wahid and H. H. Maharram, “Synthesis and Evaluation of Antitumor and Antiviral Screening of Some Newer Aryl Acrylamide Derivatives,” Mansoura Journal of Pharmaceutical Sciences, Vol. 16, 2000, pp. 98-113.
|
[8]
|
F. Shi, A. Dai, X. Zhang, B. Jiang and S. Tu, “Facile Diversity-Oriented Synthesis of Novel Dipeptide Mimetic Compounds Containing Bioactive Molecular Skeletons Under Microwave Irradiation,” ACS Combinatorial Science, Vol. 13, No. 2, 2011, pp. 147-153.
doi:10.1021/co1000458
|
[9]
|
J. Shan and J. J. Zheng, “Optimizing Dvl PDZ Domain Inhibitor by Exploring Chemical Space,” Journal of Computer-Aided Molecular Design, Vol. 23, No. 1, 2009, pp. 37-47. doi:10.1007/s10822-008-9236-1
|
[10]
|
J. Peters, “Pharmacological Promiscuity and Molecular Properties,” In: J. Peters, Ed., Polypharmacology in Drug Discovery, Wiley, Hoboken, 2012, pp. 47-59.
doi:10.1002/9781118098141.ch3
|
[11]
|
S. C. Khadse, G. S. Talele and S. S. Agrawal, “Aminocarbonyl Arylvinylbenzamides as Gastric Sparing Anti-Inflammatory Agents,” Pharmaceutical & Medicinal Chemistry, Vol. 344, No. 5, 2011 pp. 292-300.
doi:10.1002/ardp.201000096
|
[12]
|
B. H. Banu and K. Bharathi, “Synthesis and Analgesic Activity of Some N-Protected Dehydrophenylalanine Dipeptides,” Journal of Pharmacy Research, Vol. 3, No. 10, 2010, pp. 2450-2452.
|
[13]
|
M. S. Mohamed, R. K. Mahmoud, A. I. Sayed and M. E. El-Araby, “Potent Anticonvulsant 1H-Imidazol-5(4H)-One Derivatives with Low Neurotoxicity,” The Open Medicinal Chemistry Journal, Vol. 2, No. 2, 2012, pp. 24-29.
|
[14]
|
A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward and D. Forman, “Global Cancer Statistics,” A Cancer Journal for Clinicians, Vol. 61, No. 2, 2011, pp. 69-90.
doi:10.3322/caac.20107
|
[15]
|
P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenney and M. R. Boyd, “New Colorimetric Cytotoxicity Assay for Anticancer-Drug Screening,” Journal of the National Cancer Institute, Vol. 82, No. 13, 1990, pp. 1107-1112.
doi:10.1093/jnci/82.13.1107
|
[16]
|
P. Ertl, B. Rohde and P. Selzer, “Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment Based Contributions and Its Application to the Prediction of Drug Transport Properties,” Journal of Medicinal Chemistry, Vol. 43, No. 20, 2000, pp. 3714-3717.
doi:10.1021/jm000942e
|
[17]
|
J. J. Luszczki, E. Wojda, M. Andres-Mach, W. Cisowski, M. Glensk, K. Glowniak and S. J. Czuczwar, “Anticonvulsant and Acute Neurotoxic Effects of Imperatorin, Osthole and Valproate in the Maximal Electroshock Seizure and Chimney Tests in Mice: A Comparativestudy,” Epilepsy Research, Vol. 85, No. 2, 2009, pp. 293-299.
|
[18]
|
F. Lombardo, B. W. Dominy and P. J. Feeney, “Experimental and Computational Approaches to Estimate Solubility and Permeability in Drug Discovery and Development Settings,” Advanced Drug Delivery Reviews, Vol. 46, No. 1-3, 2001, pp. 3-26.
doi:10.1016/S0169-409X(00)00129-0
|
[19]
|
M. Q. Zhang, “Working with Small Molecules: Rules-of-Thumb of ‘Drug Likeness’,” Methods in Molecular Biology, Vol. 803, 2012, pp. 297-307.
doi:10.1007/978-1-61779-364-6_20
|
[20]
|
N. Saldabols, A. Treilone, L. N. Alekseeva, B. Brizga and K. Medne, “Synthesis and Transformations of Furan Derivatives. VI. Amides of β-(2-Furyl)- and
β-(5-Nitro-2-furyl)-α-acylamidoacrylic Acids and MonoSubstituted 2-Phenyl-4-(5-nitro-2-furfurylidene)-5-imidazolones,” Khimiko-Farmatsevticheskii Zhurnal, Vol. 1, 1967, pp. 21-27.
|